Stoneridge's 15% Q2 Sales Jump Looks Real-But One Bad Quarter Still Breaks the Bull Case

Stoneridge's Q2 showed better demand, but the earnings profile still lacks proof

Stoneridge's second quarter presents a mixed read. Bulls can point to Q2 sales of $181.4 million and 15.1% year-over-year growth. Bears will focus on the bottom line: the company still reported a EPS miss versus consensus of $0.08, at GAAP EPS of -$0.18. In short, demand looks better, but profitability still needs to improve.

The positive side is clear enough. Q2 losses narrowed materially, management reaffirmed 2026 guidance, and the quarter does not look like a one-off spike in activity. The caution is just as clear: better is not the same as fixed. Until revenue growth starts converting into more durable earnings, the turnaround case stays work-in-progress.

Two quarters of sales progress make the demand story more credible

The key question is not whether Stoneridge had one decent quarter. It is whether the business is improving in a repeatable way.

The sales trend is improving sequentially and year over year

Q1 sales were $160.8 million, up 9.2% from Q4 2025. Q2 then rose to $181.4 million in sales, with 15.1% year-over-year growth. That two-quarter progression is more convincing than a single strong period.

Product wins and a new award add depth to the story

MirrorEye revenue reached about $37 million in Q2, up 39% year over year, which suggests some of the growth is coming from higher-value products rather than volume alone. Stoneridge also secured a new $42 million bus and coach OEM award, described as its largest to date, with full commercialization expected in 2027. That award does not drive 2026 results, but it does make the 2027 setup more concrete.

Profitability is improving, yet margin pressure still blocks the full bull case

The quarter also showed progress in efficiency. Adjusted EBITDA rose to $5.5 million, up 251 basis points year over year. Q1 had already pointed in the same direction, with adjusted EBITDA of $2.0 million and adjusted operating margin improving 180 basis points versus Q4 2025. Together, those quarters suggest Stoneridge is not only selling more, but also keeping a bit more of each sale.

Cash flow and balance-sheet pressure also appear less acute. Operating cash flow rose 38% year over year, and net debt fell by nearly $40 million over the past 12 months. That does not settle the turnaround case, but it does make the setup more credible.

What investors still need to see

The main unresolved issue is earnings quality. Gross margin fell 277 basis points to 20.3%, and the company cited higher material costs, currency translation losses, and inventory-related charges. More revenue is not enough if margin pressure keeps eating through the gains.

The next few quarters need to answer a simple question: can Stoneridge turn better demand and better cost control into consistent profitability? If the answer is yes, the bull case strengthens quickly. If not, the stock remains a promising operation with an unfinished financial story.